An in-depth look to HLB PHARMACEUTICAL operating, investing, and financing activities

047920 free cash flow for Q3 24 is 538.61 M KRW. For 2023, 047920 free cash flow was -21.04 B KRW and operating cash flow was -18.32 B KRW.